drugset / Trial / NCT00360230

Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children

NCT00360230

Phase 2 Completed 540 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindPrevention

Summary

This study will investigate the safety and immunogenicity of 2 candidate malaria vaccines administered according to 3 different vaccination schedules in 5 to 17 months old Ghanaian children. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Timeline

Start
2006-08-30
Primary completion
2007-08-25
Completion
2008-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rabies vaccine Vaccine Intramuscular
Subject SB257049 Vaccine Intramuscular

Indications